X0508 4 2023-07-01 0001402945 Progressive Care Inc. RXMD 0001509529 Fernandez Charles M. C/O NEXTPLAT CORP 3250 MARY ST., SUITE 410 COCONUT GROVE FL 33133 1 1 1 Chairman & CEO 0 Common Stock 2023-07-01 4 X 0 228240 2.20 A 1557356 I By eAperion Partners LLC Common Stock 2023-07-01 4 S 0 112838 4.45 D 1444518 I By eAperion Partners LLC Common Stock 2023-07-01 4 X 0 190000 2.20 A 1634518 I By eAperion Partners LLC Common Stock 2023-07-01 4 S 0 93932 4.45 D 1540586 I By eAperion Partners LLC Common Stock 2023-07-01 4 X 0 455000 2.20 A 1995586 I By NextPlat Corp Common Stock 2023-07-01 4 S 0 224944 4.45 D 1770642 I By NextPlat Corp Common Stock 2023-07-01 4 X 0 340599 2.20 A 2111241 I By NextPlat Corp Common Stock 2023-07-01 4 S 0 168386 4.45 D 1942855 I By NextPlat Corp Common Stock 2023-07-01 4 X 0 230000 2.20 A 2172855 I By NextPlat Corp Common Stock Warrant 2.20 2023-07-01 4 X 0 228240 0 A 2023-05-09 2028-05-09 Common Stock 228240 0 I By eAperion Partners LLC Common Stock Warrant 2.20 2023-07-01 4 X 0 190000 0 A 2023-05-09 2026-05-09 Common Stock 190000 0 I By eAperion Partners LLC Common Stock Warrant 2.20 2023-07-01 4 X 0 455000 0 A 2023-05-09 2026-05-09 Common Stock 455000 0 I By NextPlat Corp Common Stock Warrant 2.20 2023-07-01 4 X 0 340599 0 A 2023-05-09 2026-05-09 Common Stock 340599 0 I By NextPlat Corp Common Stock Warrant 2.20 2023-07-01 4 X 0 230000 0 A 2023-05-09 2028-05-09 Common Stock 230000 0 I By NextPlat Corp On July 1, 2023, eAperion Partners, LLC exercised a Conversion Warrant to purchase 228,240 shares of RXMD common stock for $2.20 a share. eAperion Partners, LLC paid the exercise price on a cashless basis, resulting in RXMD's withholding of 112,838 of the warrant shares to pay the exercise price and issuing to the reporting person the remaining 115,402 shares. On July 1, 2023, eAperion Partners, LLC exercised an Inducement Warrant to purchase 190,000 shares of RXMD common stock for $2.20 a share. eAperion Partners, LLC paid the exercise price on a cashless basis, resulting in RXMD's withholding of 93,932 of the warrant shares to pay the exercise price and issuing to the reporting person the remaining 96,068 shares. On July 1, 2023, NextPlat Corp exercised a Warrant to purchase 455,000 shares of RXMD common stock for $2.20 a share. NextPlat Corp paid the exercise price on a cashless basis, resulting in RXMD's withholding of 224,944 of the warrant shares to pay the exercise price and issuing to the reporting person the remaining 230,056 shares. On July 1, 2023, NextPlat Corp exercised a Conversion Warrant to purchase 340,599 shares of RXMD common stock for $2.20 a share. NextPlat Corp paid the exercise price on a cashless basis, resulting in RXMD's withholding of 168,386 of the warrant shares to pay the exercise price and issuing to the reporting person the remaining 172,213 shares. On July 1, 2023, NextPlat Corp, exercised a Conversion Warrant to purchase 230,000 shares of RXMD common stock for $2.20 per share. NextPlat Corp paid the exercise price on a cash basis. The Reporting Person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission that the reporting person is the beneficial owner of such securities for purposes of Section 16 or for any other purpose. The Reporting Person is the sole member and managing member of eAperion Partners LLC. Includes 18,261 shares of common stock directly held by the Reporting Person; 1,071,251 shares of common stock held indirectly by NextPlat Corp., of which the Reporting Person is the Chief Executive Officer; and 239,604 shares of common stock held indirectly by eAperion Partners LLC, of which the Reporting person is the sole member and managing member. /s/ Charles M. Fernandez 2023-10-20